{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:47:24Z","timestamp":1775555244315,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pcd.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:00:15Z","timestamp":1706821215000},"page":"202-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and\/or kidney risk"],"prefix":"10.1016","volume":"18","author":[{"given":"Alexander J.","family":"Blood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-1219","authenticated-orcid":false,"given":"Lee-Shing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Colling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gabovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guinevere","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Adan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5540-5641","authenticated-orcid":false,"given":"Fanta","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3793-5240","authenticated-orcid":false,"given":"Emily","family":"Durden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Hamersky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Noone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Liberatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina S.","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-9876","authenticated-orcid":false,"given":"Jorge","family":"Plutzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah J.","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Scirica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2024.01.005_bib1","unstructured":"National Diabetes Statistics Report, 2020 | CDC, (n.d.). \u3008https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html\u3009 (Accessed 25 October 2021)."},{"key":"10.1016\/j.pcd.2024.01.005_bib2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2337\/dc13-2484","article-title":"The lifetime cost of diabetes and its implications for diabetes prevention","volume":"37","author":"Zhuo","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.01.005_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2213-8587(15)00519-7","article-title":"The rising cost of diabetes care in the USA","volume":"4","author":"Peter","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2024.01.005_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.01.005_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"76","author":"Das","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2024.01.005_bib7","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2337\/dc22-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.01.005_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(13)62329-6","article-title":"Biomedical research: increasing value, reducing waste","volume":"383","author":"Macleod","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2024.01.005_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J. R. Soc. Med"},{"key":"10.1016\/j.pcd.2024.01.005_bib10","doi-asserted-by":"crossref","DOI":"10.2337\/db22-172-OR","article-title":"172-OR: eligibility and utilization of SGLT2i and GLP1-RA in T2D by cardiovascular and renal indications","volume":"71","author":"Blood","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2024.01.005_bib11","doi-asserted-by":"crossref","unstructured":"D. Mahtta, D. Ramsey, M. Lee, \u2026 L.C.-D., undefined 2022, Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type, Am Diabetes AssocD Mahtta, DJ Ramsey, MT Lee, L Chen, M Al Rifai, JM Akeroyd, EM Vaughan, ME MathenyDiabetes Care, 2022\u2022Am Diabetes Assoc. (n.d.). \u3008https:\/\/diabetesjournals.org\/care\/article-abstract\/45\/2\/372\/139194\u3009 (Accessed October 31, 2023).","DOI":"10.2337\/dc21-1815"},{"key":"10.1016\/j.pcd.2024.01.005_bib12","doi-asserted-by":"crossref","unstructured":"N.J. Pagidipati, A.J. Nelson, L.A. Kaltenbach, M. Leyva, D.K. McGuire, R. Pop-Busui, M.A. Cavender, V.R. Aroda, M.L. Magwire, C.R. Richardson, I. Lingvay, J.K. Kirk, H.R. Al-Khalidi, L. Webb, T. Gaynor, J. Pak, C. Senyucel, R.D. Lopes, J.B. Green, C.B. Granger, C. Author, Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes A Randomized Clinical Trial Visual Abstract Supplemental content Group Information: A complete list of the COORDINATE-Diabetes Site Investigators appears in Supplement 3, (2023). https:\/\/doi.org\/10.1001\/jama.2023.2854.","DOI":"10.1001\/jama.2023.2854"},{"key":"10.1016\/j.pcd.2024.01.005_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17886","article-title":"Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease","volume":"6","author":"Luo","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pcd.2024.01.005_bib14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1055\/s-0041-1739195","article-title":"Workflow automation for a virtual hypertension management program","volume":"12","author":"Gordon","year":"2021","journal-title":"Appl. Clin. Inf."},{"key":"10.1016\/j.pcd.2024.01.005_bib15","article-title":"Population health identification and management of low density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program","author":"Plutzky","year":"2021","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pcd.2024.01.005_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.23141","article-title":"Development of an entirely remote, non-physician led hypertension management program","volume":"42","author":"Fisher","year":"2019","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.120.051913","article-title":"Digital care transformation: interim report from the first 5000 patients enrolled in a remote algorithm-based cardiovascular risk management program to improve lipid and hypertension control","volume":"143","author":"Scirica","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcd.2024.01.005_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/jamacardio.2022.4018","article-title":"Results of a remotely delivered hypertension and lipid program in more than 10\u00a0000 patients across a diverse health care network","volume":"8","author":"Blood","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jamacardio.2020.3757","article-title":"Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction","volume":"5","author":"Desai","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","article-title":"Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers","volume":"39","author":"Hibbard","year":"2004","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.pcd.2024.01.005_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2158244016668220","article-title":"Multiple imputation of multilevel missing data: an introduction to the R package pan","volume":"6","author":"Grund","year":"2016","journal-title":"Sage Open"},{"key":"10.1016\/j.pcd.2024.01.005_bib22","doi-asserted-by":"crossref","unstructured":"G.F. Liu, L. Pang, 2017. Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials, Http:\/\/Dx.Doi.Org\/10.1080\/19466315.2016.1256830. 9 (2017) 186\u2013194. https:\/\/doi.org\/10.1080\/19466315.2016.1256830.","DOI":"10.1080\/19466315.2016.1256830"},{"key":"10.1016\/j.pcd.2024.01.005_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01154-w","article-title":"Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes","volume":"19","author":"Schernthaner","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.pcd.2024.01.005_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.pcd.2024.01.005_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc22-0383","article-title":"Deficits and disparities in early uptake of glucagon-like peptide 1 receptor agonists and SGLT2i among medicare-insured adults following a new diagnosis of cardiovascular disease or heart failure","volume":"46","author":"Cromer","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.01.005_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.annemergmed.2006.08.022","article-title":"Knowledge translation: closing the evidence-to-practice gap","volume":"49","author":"Lang","year":"2007","journal-title":"Ann. Emerg. Med"},{"key":"10.1016\/j.pcd.2024.01.005_bib27","doi-asserted-by":"crossref","unstructured":"S. Dopson, L. Locock, J. Gabbay, E. Ferlie, L. Fitzgerald, 2016. Evidence-Based Medicine and the Implementation Gap:, Http:\/\/Dx.Doi.Org\/10.1177\/1363459303007003004. 7 (2016) 311\u2013330. https:\/\/doi.org\/10.1177\/1363459303007003004.","DOI":"10.1177\/1363459303007003004"},{"key":"10.1016\/j.pcd.2024.01.005_bib28","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0140-6736(12)60480-2","article-title":"Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis","volume":"379","author":"Tricco","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2024.01.005_bib29","first-page":"e122","volume":"135","author":"Chan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcd.2024.01.005_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/XCE.0000000000000199","article-title":"Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities","volume":"9","author":"Bruemmer","year":"2020","journal-title":"Cardiovasc Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2024.01.005_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamacardio.2022.4382","article-title":"Nudging to improve cardiovascular care\u2014clinicians, patients, or both","volume":"8","author":"Ahmad","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/clc.23291","article-title":"Rationale and design of a navigator\u2010driven remote optimization of guideline\u2010directed medical therapy in patients with heart failure with reduced ejection fraction","author":"Blood","year":"2020","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.pcd.2024.01.005_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jphs.12162","article-title":"Outcomes associated with pharmacist-led diabetes collaborative drug therapy management in a medicaid population","volume":"8","author":"Biltaji","year":"2017","journal-title":"J. Pharm. Health Serv. Res"},{"key":"10.1016\/j.pcd.2024.01.005_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/diaspect.27.2.131","article-title":"The patient-centered medical neighborhood and diabetes care","volume":"27","author":"Spatz","year":"2014","journal-title":"Diabetes Spectr."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:20:46Z","timestamp":1729192846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991824000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1751991824000056"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2024.01.005","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and\/or kidney risk","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}